Title : Hinokitiol inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo.

Pub. Date : 2021 Jul

PMID : 33831806






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Hinokitiol inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo. beta-thujaplicin TNF superfamily member 11 Homo sapiens
2 In this study, hinokitiol, a tropolone-related compound extracted from the heart wood of several cupressaceous plants, was found to inhibit RANKL-induced osteoclast formation and bone resorption in vitro. beta-thujaplicin TNF superfamily member 11 Homo sapiens
3 Hinokitiol inhibited early activation of the ERK, p38, and JNK-MAPK pathways, thereby suppressing the activity and expression of downstream factors (c-Jun, c-Fos, and NFATC1). beta-thujaplicin mitogen-activated protein kinase 1 Homo sapiens
4 Hinokitiol inhibited early activation of the ERK, p38, and JNK-MAPK pathways, thereby suppressing the activity and expression of downstream factors (c-Jun, c-Fos, and NFATC1). beta-thujaplicin mitogen-activated protein kinase 14 Homo sapiens
5 Hinokitiol inhibited early activation of the ERK, p38, and JNK-MAPK pathways, thereby suppressing the activity and expression of downstream factors (c-Jun, c-Fos, and NFATC1). beta-thujaplicin Jun proto-oncogene, AP-1 transcription factor subunit Homo sapiens
6 Hinokitiol inhibited early activation of the ERK, p38, and JNK-MAPK pathways, thereby suppressing the activity and expression of downstream factors (c-Jun, c-Fos, and NFATC1). beta-thujaplicin Fos proto-oncogene, AP-1 transcription factor subunit Homo sapiens
7 Hinokitiol inhibited early activation of the ERK, p38, and JNK-MAPK pathways, thereby suppressing the activity and expression of downstream factors (c-Jun, c-Fos, and NFATC1). beta-thujaplicin nuclear factor of activated T cells 1 Homo sapiens